Alcohol consumption among Canadians taking benzodiazepines and related drugs

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 3, 2009, Pages 203-210

  Veldhuizen, Scott ^a   Wade, Terrance J ^b   Cairney, John ^c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b BROCK UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Alcohol; Benzodiazepines; Drug interactions

Indexed keywords

BENZODIAZEPINE; ESZOPICLONE; HYPNOTIC AGENT; ZALEPLON; ZOLPIDEM; ZOPICLONE; ALCOHOL; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE;

ADULT; AGE; ALCOHOL CONSUMPTION; ANXIETY DISORDER; ARTICLE; CANADA; DRINKING BEHAVIOR; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TREATMENT DURATION; ADOLESCENT; AGED; DRUG INTERACTION; MIDDLE AGED; QUESTIONNAIRE; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BENZODIAZEPINES; CANADA; DRUG INTERACTIONS; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 65249114891     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1702     Document Type: Article

References (39)

1. Ashton H. Guidelines for the rational use of benzodiazepines: when and what to use. Drugs 1994; 48(1): 25-40.
2. De Las Cuevas C, Sanz E, De La Fuenta JA, Cabrera C, Mateos A. Prescribed daily doses and 'risk factors' associated with the use of benzodiazepines in primary care. Pharmacoepidemiol Drug Saf 1999; 8: 207-216. DOI:10.1002/(SICI)1099-1557
3. Möller HJ. Effectiveness and safety of benzodiazepines. J Clin Psychopharmacol 1999; 19(6): 2s-11s.
4. Boeuf O, Lapeyre-Mestre M. Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP survey. Drug Saf 2007; 30(3): 265-276.
5. Michelini S, Cassano GB, Frare F, Perugi G. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders. Pharmacopsychiatry 1996; 29: 127-134. DOI:10.1055/s-2007-979558
6. Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Eur Neuropsychopharmacol 1999; 9(6): s399: s405. DOI:10.1016/S0924-977X(99)00051-6
7. Barbone F, McMahon AD, Davey PG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet 1998; 352(9137): 1331-1336.
8. Kurzthaler I, Wambacher M, Golser K, et al. Alcohol and/or benzodiazepine use in injured road users. Hum Psychopharmacol Clin Exp 2003; 18: 361-367.
9. Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997; 278(1): 27-31.
10. Hebert C, Delaney JAC, Hemmelgarn B, Lévesque LE, Suissa S. Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs. Pharmacoepidemiol Drug Saf 2007; 26(8): 845-849.
11. Oster G, RussellMW, Huse DM, Adams SF, Imbimbo J. Accident- and injury-related health-care utilization among benzodiazepine users and nonusers. J Clin Psychiatr 1987; 48: 17-21.
12. Tamblyn R, Abrahamowicz M, du Berger R, McLeod P, Bartlett G. A 5-Year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc 2005; 53(2): 233-241.
13. Neutel CI, Hirdes JP, Maxwell CJ, Patten SB. New evidence on benzodiazepine use and falls: the time factor. Age and Ageing 1996; 25(4): 273-278.
14. MacDonald S, Wells S, Giesbrecht N, Cherpitel CJ. Demographic and substance use factors related to violent and accidental injuries: results from an emergency room study. Drug Alc Dep 1999; 55(1-2): 53-61.
15. Linnoila MI. Benzodiazepines and alcohol. J Psychiatr Res. 1990; 24(Suppl. 2): 121-127.
16. Hollister LE. Interactions between alcohol and benzodiazepines. Recent Dev Alcohol 1990; 8: 233-239.
17. Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health 1999; 23(1): 40-54.
18. van Steveninck AL, Gieschke R, Schoemaker HC, et al. Pharmacodynamic interactions of diazepam and intravenous alcohol at pseudo steady state. Psychopharmacologia 1993; 110: 471-478. DOI: 10.1007/BF02244655
19. van Steveninck AL, Gieschke R, Schoemaker HC, et al. Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol. Br J Clin Pharmacol 1996; 41: 565-573.
20. Rush CR. Behavioral pharmacology of zolpidem relative to benzodiazepines: a review. Pharmacol Biochem Behav 1998; 61(3): 253-269.
21. Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry 2005; 66(9): 31-41.
22. Beck CA, Williams JVA, Wang JL, et al. Psychotropic medication use in Canada. Can J Psychiatry 2005; 50: 605-613.
23. Dunbar GC, Morgan DDV, Perera KMH. The concurrent use of alcohol, cigarettes and caffeine in British benzodiazepine users as measured by a general population survey. Br J Addiction 1988; 83: 689-694.
24. Westra HA, Stewart SH. As-needed use of benzodiazepines in managing clinical anxiety: incidence and implications. Curr Pharm Des 2002; 8: 59-74.
25. Del Rio MC, Prada C, Alvarez FJ. Do Spanish patients drink alcohol while undergoing treatment with benzodiazepines? Alcohol 2002; 26: 31-34.
26. Dunbar GC, Perera MH, Jenner FA. Patterns of benzodiazepine use in Great Britain as measured by a general population survey. Br J Psychiatr 1989; 155: 836-841.
27. Hogan DB, Maxwell CJ, Fung TS, Ebly RM. Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian study of health and aging. Can J Clin Pharmacol 2003; 10(2): 72-77.
28. Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med 1998; 13: 243-250.
29. Gravel R, Béland Y. The Canadian community health survey: mental health and well-being. Can J Psychiatr 2005; 50: 573-579.
30. Centre for Addiction and Mental Health. Low-Risk Drinking Guidelines. Centre for Addiction and Mental Health: Toronto, ON, 2000.
31. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51(1): 8-19.
32. Kessler RC, Andrews J, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 2002; 32(6): 959-976.
33. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40(5): 373-383.
34. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatr 2005; 62: 617-627.
35. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999; 28: 964-974.
36. Rao JNK, Scott AJ. On chi-squared tests for multiway contingency tables with cell proportions estimated from survey data. Ann Stat 1984; 12: 46-60.
37. Dufour M, Fuller RK. Alcohol in the elderly. Ann Rev Med 1995; 46: 123-132. DOI:10.1146/annurev.med.46.1.123
38. Rehm J, Greenfield TK, Rogers JD. Average volume of alcohol consumption, patterns of drinking, and all-cause mortality: results from the US national alcohol survey. Am J Epidem 2001; 153(1): 64-71.
39. Casswell S, Pledger M, Hooper R. Socioeconomic status and drinking patterns in young adults. Addiction 2003; 98(5): 601-610.